1. Science For A Better Life
Perspective on Sustainability 2009
Leverkusen, November 11, 2009
Dr. Wolfgang Plischke
© Bayer AG, Leverkusen, Germany, 2009

2. Forward-Looking Statements
This presentation may contain forward-looking statements based on
current assumptions and forecasts made by Bayer Group or subgroup
management. Various known and unknown risks, uncertainties and other
factors could lead to material differences between the actual future
results, financial situation, development or performance of the company
and the estimates given here. These factors include those discussed in
Bayer’s public reports, which are available on the Bayer website at
www.bayer.com. The company assumes no liability whatsoever to
update these forward-looking statements or to conform them to future
events or developments.
© Bayer AG, Leverkusen, Germany, 2009

3. Health care challenge:
Unplanned pregnancies
210 million pregnancies each year –
76 million of them unplanned
Each year, 14 million children are
born to mothers aged between
15 and 19 – 90 percent of these in
developing countries
Sexuality is often a taboo subject in
developing countries
© Bayer AG, Leverkusen, Germany, 2009

4. Health care:
Family planning in developing countries
Bayer pursues a two-pronged approach
Promoting sex education:
Pregnancy, contraception, HIV/AIDS
Providing access to contraceptives
Over the next three years, 8 million women will benefit from
hormonal contraceptives at reduced prices
Partners include the DSW (German Foundation for World Population), USAID
and the IPPF (International Planned Parenthood Federation)
© Bayer AG, Leverkusen, Germany, 2009

5. Health care:
Tackling neglected diseases
Over 3.3 billion people are at risk
Those worst affected are
the poorest of the poor
Focal points of Bayer’s commitment:
- African sleeping sickness
- Chagas disease
- Tuberculosis
© Bayer AG, Leverkusen, Germany, 2009

6. Health care:
Treating African sleeping sickness
500,000 people in tropical Africa affected
70,000 deaths each year
Cooperation with the WHO (World Health
Organization)
Bayer provides drugs free of charge
© Bayer AG, Leverkusen, Germany, 2009

7. Health care:
Treating Chagas disease
14 million people infected
14,000 deaths each year
Cooperation with the WHO (World Health
Organization)
Bayer provides drugs free of charge and 1.5 million
U.S. dollars to support logistics operations
© Bayer AG, Leverkusen, Germany, 2009

8. Health care:
New form of treatment for tuberculosis (TB)
9 million new cases of acute TB each year
2 million deaths annually
Bayer is cooperating with the Global Alliance for
TB Drug Development to develop a new, quicker form of treatment
If the studies are successful, they will pave the way for
affordable treatment
© Bayer AG, Leverkusen, Germany, 2009

9. Challenge of feeding the world’s population
Growing demand for food
Limited amount of agricultural land available for cultivation
Crop yields at risk due to climate change
1 billion people are going hungry
© Bayer AG, Leverkusen, Germany, 2009

10. Nutrition:
Sustainable rice cultivation in Indonesia
Integrated Bayer program
New cultivation method – pregerminated rice
Provision of seeds and sowing machinery
Efficient use of crop protection agents
and fertilizers
Know-how and training
Benefits
Economic – higher yields and better quality
Ecological – reduced water consumption and 30 percent lower methane emissions
Social – farmers’ incomes improved
© Bayer AG, Leverkusen, Germany, 2009

11. Nutrition: Food Chain Partnership for
vegetables in India
Growing demand for high-quality vegetables
Tougher quality requirements from consumers
and the export trade
Bayer’s Food Chain Partnership
Tomatoes, chilies, okra, eggplant, potatoes etc.
Network of farmers, suppliers, processing industry,
retailers and exporters
Vegetable cultivation supported by 125 projects involving 65,000 farmers by 2011
Benefits
Economic – higher yields, better quality and greater sales potential
Ecological – lower land usage
Social – farmers’ incomes improved
© Bayer AG, Leverkusen, Germany, 2009

12. Challenge of climate change:
Climate protection and buildings
20 percent of global greenhouse gas emissions
generated by energy consumption in buildings
Bayer’s focus is on commercial and public
buildings – EcoCommercial Building Program
Partnership network for sustainable building
High-tech products from Bayer,
including for building insulation
© Bayer AG, Leverkusen, Germany, 2009

13. Challenge of climate change:
Climate protection and buildings
20 percent of global greenhouse gas emissions
generated by energy consumption in buildings
Bayer’s focus is on commercial and public
buildings – EcoCommercial Building Program
Partnership network for sustainable building
High-tech products from Bayer,
including for building insulation
First EcoCommercial buildings in Germany,
India and Belgium
© Bayer AG, Leverkusen, Germany, 2009

14. Challenge of climate change:
Climate protection and industrial production
With new technology developed by Bayer
and partners (oxygen depolarized cathode):
Energy consumption and CO2 emissions
cut by 30 percent in chlorine production
Acid-based industrial-scale production
already under way
Initial application based on salt by the start
of 2011 – energy consumption also 30 percent lower
International marketing of new technology based on salt
Potential CO2 reduction 5 million metric tons per year
© Bayer AG, Leverkusen, Germany, 2009